BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37229083)

  • 1. Hurthle cell carcinoma: a rare variant of thyroid malignancy - a case report.
    Adhikari Y; Marasini A; Adhikari N; Paneru LD; Upadhaya Regmi B; Raut M
    Ann Med Surg (Lond); 2023 May; 85(5):1940-1943. PubMed ID: 37229083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexistence of Oncocytic (Hürthle cell) carcinoma with foci of anaplastic carcinoma and a metastasizing papillary carcinoma in one thyroid gland: Rare case report.
    Assiri SA; Alhumaidi DA; Althagafi AA; Alkashgry SA; Alaamri HS; Khurshid A
    Int J Surg Case Rep; 2023 May; 106():108174. PubMed ID: 37058803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent Hurthle cell thyroid carcinoma does not preclude long-term survival: a case report and review of the literature.
    Blossey RD; Kleine-Döpke D; Ringe KI; Pöhnert D; Ringe B; Klempnauer J; Beetz O
    J Med Case Rep; 2021 Aug; 15(1):399. PubMed ID: 34376229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hürthle cell carcinoma of the thyroid presenting as thyrotoxicosis.
    Karanchi H; Hamilton DJ; Robbins RJ
    Endocr Pract; 2012; 18(1):e5-9. PubMed ID: 22068247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of molecular testing in the diagnosis of medullary thyroid cancer: A case report of oncocytic medullary thyroid carcinoma and review of the literature.
    Spaulding SL; Ho R; Everest S; Chai RL
    Am J Otolaryngol; 2020; 41(1):102312. PubMed ID: 31727331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm.
    Sorrenti S; Trimboli P; Catania A; Ulisse S; De Antoni E; D'Armiento M
    Thyroid; 2009 Apr; 19(4):355-60. PubMed ID: 19355826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medullary carcinoma of thyroid mimicking Hurthle cell neoplasm on cytology: a diagnostic dilemma.
    Agarwal C; Raychaudhuri S; Batra A; Pujani M; Dhingra S
    Diagn Cytopathol; 2019 Sep; 47(9):943-947. PubMed ID: 31190466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid hemiagenesis associated with Hurthle cell carcinoma: A case report.
    Kartini D; Panigoro SS; Ham MF; Harahap AS; Rasyid SH; Marcevianto KV
    Int J Surg Case Rep; 2021 Sep; 86():106372. PubMed ID: 34507192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hürthle cell thyroid carcinoma presenting as a "hot" nodule.
    Yalla NM; Reynolds LR
    Endocr Pract; 2011; 17(3):e68-72. PubMed ID: 21454238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid follicular carcinoma: sonographic features of 50 cases.
    Sillery JC; Reading CC; Charboneau JW; Henrichsen TL; Hay ID; Mandrekar JN
    AJR Am J Roentgenol; 2010 Jan; 194(1):44-54. PubMed ID: 20028904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic thyroid follicular carcinoma presenting as pathological left clavicle fracture: An unusual skeletal metastasis at the time of diagnosis.
    Nilojan JS; Raviraj S; Madhuwantha UVP; Mathuvanthi T; Priyatharsan K
    Int J Surg Case Rep; 2024 Jan; 114():109131. PubMed ID: 38128290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic Hurthle Cell Carcinoma of the thyroid presenting as a Breast Lump: A Case Report.
    Al-Abed Y; Gray E; Wolfe K; Watters GW; Philpott JM
    Int Semin Surg Oncol; 2008 May; 5():14. PubMed ID: 18505578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hürthle cell carcinoma: A malignancy of low-grade potential.
    Khafif A; Khafif RA; Attie JN
    Head Neck; 1999 Sep; 21(6):506-11. PubMed ID: 10449665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
    Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
    Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytological and molecular diagnosis of Hürthle cell thyroid tumors: Analysis of three cases.
    Titov SE; Poloz TL; Veryaskina YA; Anishchenko VV
    Mol Clin Oncol; 2021 Jul; 15(1):149. PubMed ID: 34094547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hürthle cell carcinoma: diagnostic and therapeutic implications.
    Hanief MR; Igali L; Grama D
    World J Surg Oncol; 2004 Aug; 2():27. PubMed ID: 15306032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrence of Papillary Thyroid Carcinoma and Hürthle Cell Carcinoma in an Iranian Woman with Hashimoto's Thyroiditis.
    Samiee-Rad F; Farajee S; Torabi E
    Iran J Pathol; 2019; 14(4):342-346. PubMed ID: 31754366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine needle aspiration of poorly differentiated oxyphilic (Hürthle cell) thyroid carcinoma: a case report.
    Ghofrani M; Sosa JA; Ocal IT; Angeletti C
    Acta Cytol; 2006; 50(5):560-2. PubMed ID: 17017447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotoxicosis: a rare presenting symptom of Hurthle cell carcinoma of the thyroid.
    Wong CP; AuYong TK; Tong CM
    Clin Nucl Med; 2003 Oct; 28(10):803-6. PubMed ID: 14508269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.